Investigating the role of GAPDHS in melanoma metabolism and metastasis
Investigating the role of GAPDHS in melanoma metabolism and metastasis
批准号:
10643669
负责人:
Jennifer Gibson Gill
金额:
$25.98万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2028-06-30
关键词:
AwardBiological MarkersBiological ModelsBiologyBiometryCarbonCatalytic DomainCategoriesCellsCessation of lifeCitric Acid CycleClinicalDataDedicationsDependenceDermatologyDiseaseDistantEnzymesEquilibriumExcisionGlucoseGlyceraldehyde-3-Phosphate DehydrogenasesGlycolysisGoalsHumanImmunotherapyInfusion proceduresIsotopesKnowledgeLaboratoriesMalignant NeoplasmsMediatingMedical centerMelanoma CellMentorsMentorshipMetabolicMetabolic PathwayMetabolismMolecularMutateNeoplasm MetastasisNutrientNutrient availabilityOperative Surgical ProceduresOrganOxidation-ReductionOxidative StressPathway interactionsPatientsPrimary NeoplasmProcessPyruvate CarboxylaseRegulationResearchResearch PersonnelResourcesRoleSamplingSiteSkin CancerTechniquesTestingTexasTherapeuticTimeTrainingUniversitiesbiobankbiomarker developmentcancer cellcareerclinical practicecomparison controlexperienceglucose metabolismhigh riskimproved outcomein vivoin vivo Modelinterestknowledge basemelanomamelanoma biomarkersmetabolomicsneoplastic cellnovelnovel strategiespatient derived xenograft modelprofessorprogramstargeted treatmenttherapeutic targettherapy resistanttooltranscriptome sequencingtumor metabolismtumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract:
Melanoma is the leading cause of skin cancer deaths because it metastasizes efficiently to distant organs.
Metastasis requires significant plasticity for cancer cells to survive the metabolic barriers distinct from the
original primary tumor site including higher oxidative stress, limited nutrient availability, and changing
microenvironments. The specific metabolic changes required for melanoma to undergo this process are poorly
understood. We recently identified a novel suppressor of melanoma metastasis, the enzyme glyceraldehyde 3-
phosphate dehydrogenase, spermatogenic (GAPDHS). We characterized the functional role of GAPDHS in a
patient-derived xenograft (PDX) model and demonstrated its impact on glycolysis and pyruvate carboxylase
activity. In this proposal, we will investigate the metabolic changes associated with GAPDHS that drive
metastasis and determine whether its expression can be used to predict tumor progression in melanoma
patients. Specifically, we will determine whether the enzymatic activity of GAPDHS in central glycolysis is
required for suppressing metastasis (Aim 1), if its downstream suppression of pyruvate carboxylase activity
influences metastasis (Aim 2), and whether GAPDHS expression serves as a biomarker of melanoma
metabolism and metastasis in patients (Aim 3). As an Assistant Professor of Dermatology at the University of
Texas Southwestern Medical Center, I devote 80% of my time to my research interests under the mentorship
of Dr. Ralph DeBerardinis, with the remaining time dedicated to clinical practice. My goal is to transition to a
career as a successful independent investigator overseeing my own laboratory and research program. To
achieve this, I am seeking a K08 award to provide support for an additional period of mentored research to
gain experience with cancer metabolism, biomarker development, and advanced biostatistics, which are all
necessary to achieve my research goals. With the guidance of a distinguished mentorship committee, I will
have access to the training, resources, and support necessary to establish a successful independent research
program focused on identifying metabolic vulnerabilities in melanoma metastasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金